Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial

Table 1

Clinical characteristic of patients. It represents age, body mass index (BMI), total cholesterol levels, estrogen receptor (ER), and progesterone receptors (PR), as well as the HER-2 status in different groups.

Clinical parameters	Control (𝑛=20)	Ca (𝑛=20)	UtCa (𝑛=20)
Age interval	32–79	32–71	40–75
Mean age	56.5±11.6	55.0±9.7	54.4±11.0
BMI	25.0±1.93	27.27±1.49	26.82±5.03
Cholesterol levels	202.5±1.90	238.9±57.9	244.2±44.5
Estrogen receptor status (ER)
Positive	—	+14	+17
Negative	—	−6	−3
Progesterone receptor status (PR)
Positive	—	+10	+11
Negative	—	−10	−9
HER-2 receptor status (HER2)^*
Positive	—	+2	+6
Negative	—	−16	−12

The results for ER, HER2, and REP are represented as positive and negative numbers for the expression of receptors by number of women, while other parameters are expressed as mean ± standard deviation. UtCa group: patients treated with chemotherapy +300 mg Uncaria tomentosa daily (𝑛=20); Ca group: patients received chemotherapy (𝑛=20); control group (𝑛=20).
^*To HER-2 receiver only data were obtained from 18 patients.